(2025) [40], were conducted in adults with obesity (typically BMI 30 kg/m 2 ), most of whom had comorbid type 2 diabetes and consistently excluded individuals with active, severe, or unstable psychiatric disorders
In the UK, NICE recommends GLP-1 receptor agonists for type 2 diabetes under specific circumstances, typically when metformin and other treatments have not achieved glycaemic targets, or in people with specific cardiovascular risk factors
Dental pain might require short-term ibuprofen, which is generally acceptable
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice
If you are considering berberine alongside a compounded GLP-1 medication like semaglutide injection or tirzepatide, understanding your genetic predispositions in glucose and peptide pathways can support a more personalized conversation with your provider about timing, dosing, and monitoring needs
[Anti-arrhythmia treatment using L-carnitine in acute myocardial infarct]